DRKS00032547已完成Unknown
Evaluation of the Impact of mebix in Patients with Type II Diabetes mellitus in daily practice - EDDYII
niversitätsklinikum Carl Gustav Carus der Technischen Universität Dresden Medizinische Klinik III Abteilung Prävention und Versorgung des Diabetes0 个研究点目标入组 48 人开始时间: 2023年8月24日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Patients = 18 years old
- •Type 2 diabetes patients benefitting from improved self-management
- •Patients using/willing to use a Diabetes DiGA as part of their diabetes management
- •HbA1c at baseline = 7,5 % and = 11.0 %
- •Patients with internet access and a computer and/or smartphone compatible with the Vitadio DiGA
- •Digital literacy to use a smartphone adequately and willing to use it for their diabetes self-management
- •Sufficient understanding of user interface (UI) of the Vitadio DiGA
- •Participants willing and able to comply with all scheduled visits, laboratory tests, lifestyle considerations and other study procedures
- •Participants capable of giving personal informed consent
排除标准
- •Patients using other Apps for their diabetes management
- •Patients who have been using a Diabetes DiGA in the past twelve months
- •Patients with impairments – including mental or psychic impairments – or conditions which, in the opinion of the investigator, would seriously compromise the integrity of the study
- •Patients under 18 years of age
- •Patients participating in a weight loss program in the last 6 months
- •Patients treated with an insulin pump or continuous glucose management (CGM)
研究者
相似试验
进行中（未招募）
1 期
A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-Small Cell Lung Cancer, or Melanoma That Has Spread to the BraiEUCTR2014-004010-28-ATEli Lilly and Company247
进行中（未招募）
1 期
A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer That Has Spread to the BraiBrain tumours, Breast CancerMedDRA version: 18.0Level: LLTClassification code 10027475Term: Metastatic breast cancerSystem Organ Class: 100000004864EUCTR2014-004010-28-FREli Lilly and Company120
进行中（未招募）
1 期
A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-Small Cell Lung Cancer, or Melanoma That Has Spread to the BraiEUCTR2014-004010-28-ITELI LILLY & COMPANY, LILLY CORPORATE CENTER162
进行中（未招募）
1 期
A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-Small Cell Lung Cancer, or Melanoma That Has Spread to the BraiBrain tumours, Breast Cancer, Non-Small Cell Lung Cancer, MelanomaMedDRA version: 20.0Level: LLTClassification code 10027475Term: Metastatic breast cancerSystem Organ Class: 100000020826EUCTR2014-004010-28-BEEli Lilly and Company251
进行中（未招募）
1 期
A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-Small Cell Lung Cancer, or Melanoma That Has Spread to the BraiBrain tumors, Breast CancerMedDRA version: 18.1Level: LLTClassification code 10027475Term: Metastatic breast cancerSystem Organ Class: 100000004864EUCTR2014-004010-28-ESilly S.A.247